BriaCell Therapeutics could access a $1-$5 billion market upon approval despite a sub-$30 million cap. See more on BRIA stock ...

Denmark's Lundbeck has said that efforts to build its R&D portfolio are on track to deliver four new molecular entities (NMEs ...

NIOSH has awarded three innovative solutions for improving real-time respirator fit evaluation as part of its $350,000 ...

Project on offer comprises the first phase of Aramco’s accelerated carbon capture and storage (ACCS) development, which is ...

KLEE 2024 three year and 5 year LLB provisional allotment result out. Students can download allotment PDF at ...

The final phase of the Interstate 30 eastbound Arkansas River Bridge project is set to place from Nov. 1-4. Here's what ...

Crypto.com Arena, which celebrated its 25th anniversary this month, has completed phase three of its nine-figure, ...

Wuthering Waves version 1.3 phase II is out now It brings a plethora of in-game events Version 1.3 previously introduced a ...

Pharmaceuticals and Sobi announced that results from the Phase 3 VALIANT study were presented as an oral presentation during the High-Impact Clinical Trials session at the American Society of ...

The Office of the Commissioner for Entrance Examinations (CEE) Kerala has released the provisional allotment results for the ...

Otsuka Pharmaceutical’s kidney disease drug has hit the primary endpoint of a phase 3 trial by demonstrating in an interim ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on ...